Chambers Michael Andrew

Chambers Michael Andrew is listed in filings as Director at Sarepta Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Sarepta Therapeutics, Inc. (SRPT). The current snapshot covers public activity from Aug 20, 2024 to Jun 5, 2026. Reported amounts are shown as $477.7K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.